Algert Global LLC lifted its stake in Plexus Corp. (NASDAQ:PLXS - Free Report) by 121.3% during the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 101,336 shares of the technology company's stock after buying an additional 55,546 shares during the quarter. Plexus makes up 0.4% of Algert Global LLC's holdings, making the stock its 24th largest position. Algert Global LLC owned about 0.37% of Plexus worth $15,857,000 as of its most recent filing with the Securities & Exchange Commission.
Other institutional investors also recently bought and sold shares of the company. AXA S.A. grew its stake in shares of Plexus by 4.1% during the 4th quarter. AXA S.A. now owns 36,794 shares of the technology company's stock worth $5,758,000 after purchasing an additional 1,451 shares during the period. Schonfeld Strategic Advisors LLC purchased a new position in Plexus in the fourth quarter valued at $321,000. Northern Trust Corp increased its holdings in Plexus by 10.0% in the fourth quarter. Northern Trust Corp now owns 332,100 shares of the technology company's stock valued at $51,967,000 after buying an additional 30,163 shares in the last quarter. Tudor Investment Corp ET AL acquired a new position in shares of Plexus in the fourth quarter worth about $5,037,000. Finally, Aquatic Capital Management LLC grew its position in shares of Plexus by 134.0% during the 4th quarter. Aquatic Capital Management LLC now owns 234 shares of the technology company's stock valued at $37,000 after acquiring an additional 134 shares during the period. 94.45% of the stock is currently owned by hedge funds and other institutional investors.
Analyst Ratings Changes
A number of equities analysts have issued reports on the company. Benchmark lowered their price target on Plexus from $170.00 to $160.00 and set a "buy" rating on the stock in a research report on Friday, April 25th. Needham & Company LLC reissued a "buy" rating and issued a $162.00 price target (down previously from $172.00) on shares of Plexus in a report on Friday, April 25th. Finally, Stifel Nicolaus set a $145.00 price objective on shares of Plexus in a research report on Thursday, April 24th. Two investment analysts have rated the stock with a hold rating and three have given a buy rating to the company's stock. According to data from MarketBeat.com, the company currently has a consensus rating of "Moderate Buy" and a consensus price target of $155.67.
Get Our Latest Stock Analysis on Plexus
Insider Buying and Selling at Plexus
In other news, insider Frank Zycinski sold 1,200 shares of the firm's stock in a transaction that occurred on Monday, February 10th. The shares were sold at an average price of $140.84, for a total transaction of $169,008.00. Following the completion of the sale, the insider now owns 723 shares in the company, valued at $101,827.32. This trade represents a 62.40 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director Randy J. Martinez sold 887 shares of the firm's stock in a transaction on Tuesday, February 18th. The stock was sold at an average price of $140.52, for a total value of $124,641.24. Following the sale, the director now directly owns 4,831 shares of the company's stock, valued at approximately $678,852.12. This trade represents a 15.51 % decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 5,337 shares of company stock worth $746,924 in the last three months. 1.76% of the stock is owned by corporate insiders.
Plexus Price Performance
NASDAQ PLXS traded down $0.97 during mid-day trading on Friday, hitting $125.57. The stock had a trading volume of 51,248 shares, compared to its average volume of 188,615. Plexus Corp. has a twelve month low of $100.96 and a twelve month high of $172.89. The company has a debt-to-equity ratio of 0.07, a current ratio of 1.53 and a quick ratio of 0.70. The firm's 50 day moving average is $124.02 and its 200 day moving average is $143.43. The stock has a market capitalization of $3.40 billion, a price-to-earnings ratio of 29.13 and a beta of 0.80.
Plexus (NASDAQ:PLXS - Get Free Report) last posted its quarterly earnings results on Wednesday, April 23rd. The technology company reported $1.66 earnings per share for the quarter, topping analysts' consensus estimates of $1.54 by $0.12. The firm had revenue of $980.17 million for the quarter, compared to analyst estimates of $980.07 million. Plexus had a net margin of 3.03% and a return on equity of 10.36%. Plexus's quarterly revenue was up 1.4% on a year-over-year basis. During the same period in the previous year, the business posted $0.94 earnings per share. Equities research analysts forecast that Plexus Corp. will post 5.9 earnings per share for the current fiscal year.
Plexus Profile
(
Free Report)
Plexus Corp. provides electronic manufacturing services in the United States and internationally. It offers design, develop, supply chain, new product introduction, and manufacturing solutions, as well as sustaining services to companies in the healthcare/life sciences, industrial/commercial, aerospace/defense, and communications market sectors.
Featured Stories

Before you consider Plexus, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Plexus wasn't on the list.
While Plexus currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know? MarketBeat just compiled its list of the twelve stocks that corporate insiders are abandoning. Complete the form below to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.